Results 241 to 250 of about 122,919 (308)
ALFQ adjuvanted HIV-1 envelope protein vaccination elicits durable functional antibody and cellular responses in nonhuman primates. [PDF]
Shrivastava S +36 more
europepmc +1 more source
Aims The repurposed use of favipiravir in COVID‐19 has been reported to have limited clinical efficacy, yet it has been widely used in some countries. Favipiravir causes mutagenesis in RNA viruses, and it is currently unknown whether it may have a measurable effect on the virus in humans.
Akosua A. Agyeman +9 more
wiley +1 more source
Characterising concerns and misinformation shaping global HIV vaccine confidence and demand: a structured literature search and content analysis. [PDF]
Bokolo S +7 more
europepmc +1 more source
Introduction Introduction Reporting adverse drug reactions (ADRs) is essential for detecting drug risks. Despite legal obligations in Switzerland, underreporting remains an issue. This study assessed practice, knowledge and attitudes towards the spontaneous ADR reporting system among physicians and pharmacists.
Fiona A. Strobel +2 more
wiley +1 more source
Garrod lecture: achieving the UNGA AMR mortality reduction goals. [PDF]
Laxminarayan R.
europepmc +1 more source
Abstract In early childhood education many researchers and professionals across the world have embraced the United Nations Convention on the Rights of the Child's requirement to include young children in decision‐making. In the context of ongoing discussion about young children's capacity to share their views and opinions about matters affecting them ...
Laura Lundy +3 more
wiley +1 more source
Effectiveness of interventions to increase vaccine uptake: component network meta-analysis.
Davies SR +15 more
europepmc +1 more source
IgG and Fc Receptor Genetic Variation Associates With Functional Antibody Responses in a DNA and Protein Candidate HIV Vaccine Trial. [PDF]
Conley HE +11 more
europepmc +1 more source

